fda compounding semaglutide warning november 2025 Societies take stand against off-brand GLP-1s over safety concerns Diabetes advocacy group discourages use

Can Supergut claim the alternative Ozempic market

Pack in the protein : Getting enough protein is vital to minimizing muscle loss on GLP-1s

Effect of the glucagon-like peptide-1 receptor agonists on autonomic function in subjects with diabetes: a systematic review and meta-analysis

Low incidence of seizures has been reported with oral doses in individuals with or without a pre-existing seizure disorder

When you stop taking a GLP-1 drug, some of the effects you experienced while on the medication may reverse: Increased appetite and cravings: Without the appetite-suppressing effects of the medication, many people notice a return of hunger and stronger food cravings

The new medications have generated enormous public interest for their potential to confer wider-ranging health benefits, but scientists caution that these claims are as yet unsupported by solid clinical trial data